Dr. Andrzej Jan Barwijuk, MD, Chairman Dr. Andrzej Barwijuk is a specialist in obstetrics and gynecology. He has graduated from the Medical University of Bialystok, Poland. In 1995-2006 was the lead of the gynecological department in the St. Family's Hospital in Warsaw. During his medical practice he gained many years’ experience as a Principal Investigator in all phases of clinical trials. He is a member of: The American Cosmetic Gynecology Society (FACOG, ISC), Foundation of the American Association of Gynecologic Laparoscopists (FAAGL), Polish Gynecological Society (PTG) and Polish Video Surgical Society (PTW).
Adrian Piticas, MD, Member & Director for Romania Operations
Dr. Piticas graduated from Targu Mures Medical and Pharmaceutical University. He completed his MBA in 2006 through the Academy of Economic studies from the Romanian-Canadian MBA program in action–class, specializing in marketing. Dr. Piticas has worked for large global pharmaceutical companies in their European offices dealing with the manufacture of medical products such as entheral and infusion nutrition products, volume plasma substitute, and infusion solutions. Dr. Piticas has also been responsible for the production, import and distribution of products to the pharmaceutical market.
Adda DiLazzaro, MD , Member & Director for Romania Operations
Dr. DiLazzaro has attended many training programs held by prestigious international pharmaceutical companies, worked as a medical representative, and is presently a Business Unit Manager for a Hepatitis study. Dr. di Lazzaro was involved in special projects as the Fraxiparine transfer project team leader in the development of Marketing Excellence Program for Brand Managers and the Electronic Territory Management System. Dr. di Lazzaro brings experience in marketing management of all promotional activities, market analysis, and managed market research programs necessary to aid the development of brand strategies. Dr. di Lazzaro has also managed media and advertising agencies, ensuring effective and efficient media plans are developed, implemented and evaluated qualitatively and quantitatively.
Vasile Piticas, MS, Member & Director for Romania Operations
Mr. Piticas has over 15 years domestic and international experience in business like: Management of Investments; Constructions; Recruitment Services; Human Resources; Wine Industry. He is leading 5 companies with 157 employees with a total yearly net income of 23MIL Euro as of 2005 Annual Reporting. His companies made joint ventures with USA-IT, a major US cultural exchange and training organization to offer an outstanding program for qualified Romanian who wishes to gain valuable experience with a US company and benefit from the cultural exchange by living and working in the United States. Also, his companies are a Complete Computer Added Design Solution Provider & Complete Web Solution Provider, focused on CAD projects and IT/Web E-commerce services.
Boyan Doganov, MD Member & Director for Bulgaria Operations
Dr. Doganov brings 25+ years’ experience as a medical doctor including managing clinical research, multi-center clinical trials, community organization, research administration, and research ethics. He has conducted research for multiple European and Bulgarian pharmaceutical companies. Dr. Doganov is the Director of International Projects at the International Health Care & Health Insurance Research Institute in Bulgaria and possesses excellent written and verbal English skills in addition to his native Bulgarian.
Nelly Tzolova, MD, Member & Director for Bulgaria Operations
Dr. Tzolova, MD is a specialist in internal medicine, subspecialist in oncology; she has been working in the field of clinical research as a project manager. Dr. Tzolova has over 10 years of experience in organizing, designing and supervising of clinical trials in all phases, for multiple companies. She is member of the Bulgarian Association of Clinical Research, a major clinical research organization in Eastern Europe.
Przemyslaw Radiszewski, MD Member & Director for Poland Operations
Dr. Radziszewski has been involved in many phase clinical trials; for the last several years he has worked as a Clinical Representative for International Pharmaceutical Corporations. Dr. Radziszewski is surgeon at the Independent Surgical and Orthopedic Outpatient Clinic in Poznan, Poland, and speaks excellent English in addition to his native Polish.
George Grunberger, MD – Chairman
Dr. Grunberger is an experienced diabetologist who brings more than 25 years’ experience
of basic and clinical research into Endocrinology and Metabolism. Dr. Grunberger
reviews articles and federal grant applications and is regularly approached by industry
to review and then conduct research proposals; he is presently performing multiple
clinical trials for the industry. The first 6 years of Dr. Grunberger’s career were
completed in Bethesda, MD, at the Diabetes Branch, National Institute of Arthritis,
Diabetes, Digestive and Kidney Diseases, National Institutes of Health. Dr. Grunberger’s
research interests span the spectrum of subjects related to diabetes and its complications
from the very basic to clinical research of diabetes and its management. Dr. Grunberger
received his MD at the New York University School of Medicine and was Director of
the Diabetes Program at the Detroit Medical Center for 16 years in addition to being
Medical Director of Wayne State University’s Morris J. Hood Comprehensive Diabetes
Center, Detroit, MI. In addition to his research endeavors, Dr. Grunberger has led
a productive career as an educator and has published over a hundred original peer-reviewed
manuscripts, review articles, abstracts, book chapters, letters to journals, and
is currently co-editor of two professional journals. Dr. Grunberger is the founder
and chairman of the Grunberger Diabetes Institute and Clinical Professor, Department
of Internal Medicine, Center for Molecular Medicine and Genetics, Wayne State University
School of Medicine, Detroit, MI.
Ernest Yoder, MD, PHD, FACP.,Vice Chairman and Director of Academic Programs
Dr. Yoder is the St. John Health vice president of research and academic affairs.
Prior to this role he held several leadership positions including Medical Director
of Medicine, Residency Programs Director and Wayne State University Internal Medicine
Program Director. Dr Yoder is a leading teacher, key thought leader and researcher
who served the South East Michigan community health care for more than 30 years.
Dr Yoder is Six Sigma process trained and maintain strong understanding of administrative
and quality control tools fundamental to conducting research in health care. His
research interests focus primarily on evaluation (reliable and valid methodology)
with other scholarly work in instructional design and curriculum development (especially
in evidence-based medicine). A primary area of academic interest is in Health Care
Process Improvement and Evidence Based Medicine. Another area of interest is the
application of Mission-Based Management methodology in the medical school, particularly
at the departmental level. Dr. Yoder has published many scientific books; he coordinated
the writing of different scientific abstracts and participated in many conferences
and workshops where he received many honors and awards.
Max Rashed, MS, MBA, COO,Director of Business Development
Mr. Rashed brings extensive experience in operations, financial and asset management
working for top Fortune 500 companies. Mr. Rashed held executive leadership position
in the Drug Development Industry managing several aspects of the clinical research
at global levels interfacing with Sponsors, Health Institutions and other stake
holders in the industry. During his career, Max assisted in managing of operations
that had annual budgets that exceeded $8 billion. His experience background includes
operations and logistics across the value stream map and leadership roles across
a wide range of business activities. Max completed in 2000 an Executive Masters
of Business Administration from Michigan State University. He brings to the company
an entrepreneur’s enthusiasm, dedication and total commitment.
David M. Svinarich, Ph.D. Associate Chairman, IRB
St. John Health System Cardiovascular Research Network and the director of patient
care research at Providence hospital. He acquired in 1989 a PhD in Microbiology
and Immunology from the School of Medicine at Wayne State University; in 1984 a
Masters degree in Biology from Wayne State University and in 1983, a Bachelor degree
in Microbiology from the University of Michigan. Dr Svinarich was appointed to several
faculty positions including senior scientist at the NIH, Assistant Professor, Department
of Obstetrics and Gynecology, Department of Pediatrics, Department of Immunology
and Microbiology, Center for Molecular Medicine and Genetics, at Wayne State University
School of Medicine. Dr. Svinarich is Controlled Substance Licensed in the State
of Michigan. He chaired the Providence Hospital IRB from 2002 to 2004, and currently
serves as a member. Dr Svinarich lead numerous research projects and serve on the
scientific advisory of drug development and medical devices development studies.
He is a member of several academic societies and acquired many honors and rewards.
Jaswinder Grewal-Karwa, Ph.D, Director, Oncology Clinical Trials & Research
Dr Grewal-Karwa is responsible on the clinical trials and research of Oncology and
support other therapeutic areas at limited capacity. She brings to the Center more
than 13 years of experience in clinical research. She Developed oncology research
consortium within the various hospitals in St. John Health and created policies
and procedures for conducting trials via St. John Research Consortium. Her experience
range from managing several clinical trials and overseeing daily operation to the
overall strategic planning for the center. She assisted in setting the GCP-ICH standards
and lead Data management requirements for clinical research. Dr. Grewal-Karwa acquired
her BS in Biology and Chemistry in 1984 and her PhD in Biochemistry in 1991.
Jaswinder Grewal Ph.D,CRC training and recruitment
---------------Comming Soon -------------------
Victoria Kamal, RN, MBA, Associate Chairman, Quality control & Auditing
---------------Comming Soon -------------------
Marc Rich, MS, MBA, Financial Strategy, Acting CFO
Mr. Rich brings extensive experience in operations, budgeting, and financial planning
at a top Fortune 500 Company where he held senior positions. His experiences include
engineering, budgeting for large projects and large organizations, managing resources,
customer service, quality control (ISO_9000 and 6 sigma processes), and typical
line organizational metrics. Mr. Rich has a Bachelors and Masters of Science degree
in Metallurgical Engineering from Wayne State University, Detroit, MI, and completed
his Executive Masters of Business Administration at Michigan State University. Prior
to this position, Mr. Rich worked for Detroit Edison at a senior leadership position
as Director. During his career at Edison he was a two-time recipient of highest
award for outstanding achievement. Mr. Rich is an is expert in lean operating principals
and is a registered Professional Engineer in the state of Michigan. He is visionary,
committed to value creation principles.
Doug Rich, MBA, Financial Strategy
Steve Lerner, MD, National & International Clinical Studies Liaison Director
Dr. Lerner is an acknowledged thought leader and cutting-edge researcher in the
area of Infectious Diseases. Dr. Lerner sat on the Veterans Administration Merit
Review Subcommittee for Infectious Diseases, Ad Hoc, and is presently a member of
the Michigan Antibiotic Resistance Reduction (MARR) Coalition, the Pan American
Health Organization Technical Advisory Group on Antibiotic Resistance in Latin America,
the US National Committee for the International Union of Microbiological Societies,
in addition to others. Dr. Lerner is a graduate of MD, Magna cum Laude, Harvard
Medical School, Boston, MA, and is currently Adjunct Graduate Faculty (Professor),
Department of Biochemistry and Molecular Biology, Associate Dean for Faculty Affairs
and Professor of Medicine, Wayne State University School of Medicine, Detroit, MI.
He is a member of the Editorial Board of “Antimicrobial Agents and Chemotherapy”
and his research work is distinguished by many publications including abstracts,
reviewed articles, chapters, books, book reviews and case reports.
Peter LeWitt, MD, Central Nervous Systems Clinical Research Director
Dr. LeWitt is an acknowledged thought leader/researcher in Neurology and Movement
Disorders, and has numerous contacts globally with investigators performing leading
edge research. Dr. LeWitt serves as a consultant/investigator to many U.S. and international
pharmaceutical firms in drug development and clinical trials related to neurological
disorders. Dr. LeWitt is president of the International Essential Tremor Foundation
and the Michigan Parkinson Foundation, and has directed the National Parkinson Foundation’s
Center of Excellence in Michigan. Dr. LeWitt is editor-in-chief of Clinical Neuropharmacology
and previously served on the editorial boards of Movement Disorders and Acta Neurologica
Scandinavica. Dr. LeWitt is the author of more than 300 publications on clinical
and basic neuroscience and in 1999 edited Parkinson’s Disease: The Treatment Options.
Dr. Lewitt received his MD from Brown University, with additional post-graduate
medical and research training at the University of Pennsylvania School of Medicine,
Stanford University School of Medicine, and the NIH where he served as a clinician
researcher in the Experimental Therapeutics Branch, National Institute of Neurological
and Communicative Disorders and Stroke. Dr. LeWitt is currently Professor of Neurology,
Psychiatry and Behavioral Neuroscience at Wayne State University School of Medicine
in Detroit, MI, and interim Chairman of Neurology and Director of the Neuroscience
Laboratory Research Program at William Beaumont Hospital. Since 1994 he has been
listed in “The Best Doctors in America”.
Dr. Ayad Al-Katib, MD, Oncology/Hematology Clinical Research Director
Dr Al-Katib is the medical director of the St. John Hospital & Medical Center, Van
Elslander Cancer Center. Licenced Medical Doctor in the States of Michigan and New
York and a licensed Principle Investigator with the National Cancer Institute; Dr
Al-Katib is Board certified in Medicine (81), Hematology (86) and Medical Oncology
(87).
Dr Al-Katib held several faculty and administration appointments at Wayne State
University including chief of Lymphoma/Myeloma Service within the Division of Hematology
and Oncology, Associate Director for Hematology. Also held other appointments as
Director, Multidisciplinary Lymphoma Group, Karmanos Cancer Institute and Chairman
of the Bryostatin Investigators Consortium (Henry Ford Hospital, VA, and WSU).
He is a member of numerous national and international medical committee and a reviewer
on several journals. He is highly published (114 journal papers, 6 books, 136 abstracts)
. Dr. Al-Katib is sought key thought leader and frequently invited to industry events
and medical conferences. Dr Al-Katib is leading Oncology/Hematology research at
Detroit Clinical Research Center coordinating the overall strategy and implementation
of clinical trials.
Dr. Robert Welch, MD, Obstetrics and Gynecology Clinical Research Director
Dr. Welch, MD, FACOG, is Providence's Chairman of Obstetrics and Gynecology. Dr.
Welch is also Section Chief and Program Director of the Reproductive Endocrinology
Department at Providence Hospital. His area of special expertise is Maternal-Fetal
Medicine which includes management of high-risk pregnancy. A graduate of the Louisiana
State University School of Medicine, Dr. Welch completed his internship and residency
in OB/GYN and his fellowship in Maternal-Fetal Medicine at Wayne State University
Affiliated Hospitals. He also has done a faculty fellowship at Wayne State University.
Dr. Welch lectures nationally on current management issues in obstetrics. He has
published over 30 scientific papers and over 20 chapters on high-risk pregnancy.
He also holds nine medical patents. He is a full-faculty Associate Professor of
Obstetrics and Gynecology at Wayne State University. Among numerous society memberships,
he is a Fellow of the American College of Obstetrics and Gynecology, the Society
of Perinatal Obstetricians and American Institute of Ultrasound in Medicine.
Thomas Lalonde, MD, Cardiology Clinical Research Director
Dr. LaLonde is a cardiologist specializing in clinical, invasive and interventional
cardiology. He currently serves as medical director of the cardiac catheterization
lab and director of the interventional cardiology training program at St. John Hospital
and Medical Center in Detroit. Dr. LaLonde has completed special training to be
certified in several interventional procedures such as: directional coronary atherectomy;
transluminal extraction coronary atherectomy; coronary stent placement; rotational
atherectomy and rheolytic thrombectomy. As a clinical assistant professor of medicine
at Wayne State University, Dr. LaLonde teaches medical students and residents in
cardiology and invasive/interventional cardiology. A widely-published author in
the medical literature, Dr. LaLonde also has participated in more than 15 sponsored
clinical research trials. Dr. LaLonde has been recognized as a “Top Doc” each year
for the last 10 years in Hour Detroit magazine’s annual survey.
Robert Singer, MD,Dermatology Clinical Research Director
Dr. Singer is the Section Chief of Dermatology at Providence Hospital. Dr Singer
is ABMS Board of Dermatology in the State of Michigan. He completed his medical
education from the University of Michigan and his residency training at the University
of California. Dr. Singer is leading Clinical research in Dermatology at Detroit
Clinical Research Center.
Dr. Kapoor brings over 20 years domestic and international experience covering and
interfacing many aspects of global health care, business operations, due diligence,
marketing/sales, finance, legal, medical, and scientific affairs for top Fortune
100 and start up companies. His experiences include Quality, Regulatory Affairs,
Product Development and Operations, knowledge in GMP and GCP covering FDA and European
inspections of facilities world-wide. He has done oversight for all aspects of clinical
trials including audits, PAIs, oversight of CROs, SMOs, investigator site monitoring
and ensuring GCP compliance from Phase I to Phase IV for products in clinical trials.
Dr. Kapoor received his PhD at the University Lancaster, England, and his MBA from
Suffolk University in Boston, MA.
Shahid Jamil, MD, Psychiatric and Behavioral Disorders Clinical Research Director
Dr. Kapoor brings over 20 years domestic and international experience covering and
interfacing many aspects of global health care, business operations, due diligence,
marketing/sales, finance, legal, medical, and scientific affairs for top Fortune
100 and start up companies. His experiences include Quality, Regulatory Affairs,
Product Development and Operations, knowledge in GMP and GCP covering FDA and European
inspections of facilities world-wide. He has done oversight for all aspects of clinical
trials including audits, PAIs, oversight of CROs, SMOs, investigator site monitoring
and ensuring GCP compliance from Phase I to Phase IV for products in clinical trials.
Dr. Kapoor received his PhD at the University Lancaster, England, and his MBA from
Suffolk University in Boston, MA.
